The BioPharm Brief: New Glioblastoma Combo Immunotherapy Advances Adaptive Neuro-Oncology Trials

Welcome to The BioPharm Brief, your daily snapshot of key developments in biopharmaceutical research and clinical innovation. Today we’re looking at a new collaborative immunotherapy approach for one of the most challenging solid tumors, glioblastoma multiforme, and what it could mean for future neuro‑oncology strategies.